VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
VentiRx has assembled a team of experienced biotechnology professionals with decades of business development and drug development experience in various therapeutic areas.
VentiRx was founded in June 2006 by Michael Kamdar and Robert Hershberg, M.D., Ph.D. along with Frazier Healthcare and ARCH Venture Partners. VentiRx is a privately held organization headquartered in San Diego, CA with operations in Seattle, WA.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 03/01/07 | Series A | 26.6M | Unknown |